{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:43:39Z","timestamp":1766551419169,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["n 282378"],"award-info":[{"award-number":["n 282378"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Sequential infections of humans by the four different dengue serotypes (DENV-1\u20134) lead to neutralizing antibodies with group, cross, and type specificity. Virus neutralization of serotypes showed monotypic but mostly multitypic neutralization profiles due to multiple virus exposures. We have studied neutralization to heterologous, reference DENV serotypes using paired sera collected between days 6 and 37 after onset of fever. The DENV-primed neutralization profile of the first serum sample, which was monitored by a foci reduction neutralization test (FRNT), was boosted but the neutralization profile stayed unchanged in the second serum sample. In 45 of 47 paired serum samples, the predominant neutralization was directed against DENV serotypes distinct from the infecting serotype. Homologous neutralization studies using sera and viruses from the same area, 33 secondary sera from DENV-1 infected Cambodian patients and eight virus isolates from Cambodia, showed that the FRNT assay accurately predicted the lack of a predominant antibody response against the infecting DENV-1 serotype in contrast to FRNT results using the WHO set of DENV viruses. This report provides evidence that DENV-primed multitypic neutralizing antibody profiles were mainly boosted and stayed unchanged after secondary infection and that DENV neutralization was predominantly directed to heterologous DENV but not against the infecting homologous serotype.<\/jats:p>","DOI":"10.3390\/v13101957","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:59:47Z","timestamp":1633917587000},"page":"1957","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-7618","authenticated-orcid":false,"given":"Heidi","family":"Auerswald","sequence":"first","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"},{"name":"Virology Unit, Institut Pasteur in Cambodia, Phnom Penh 12201, Cambodia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Kann","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6972-1119","authenticated-orcid":false,"given":"Leonard","family":"Klepsch","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"H\u00fclsemann","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Rudnik","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Buchy","sequence":"additional","affiliation":[{"name":"Virology Unit, Institut Pasteur in Cambodia, Phnom Penh 12201, Cambodia"},{"name":"GlaxoSmithKline, Vaccines R&D, Singapore 139234, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Department of Virology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.99.2.291","article-title":"Dengue virus identification by the plaque reduction neutralization test","volume":"99","author":"Russell","year":"1967","journal-title":"J. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4269\/ajtmh.1983.32.164","article-title":"Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay","volume":"32","author":"Henchal","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7883\/yoken1952.38.217","article-title":"Serotyping of dengue viruses by an enzyme-linked immunosorbent assay","volume":"38","author":"Nawa","year":"1985","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Santiago, G.A., Vergne, E., Quiles, Y., Cosme, J., Vazquez, J., Medina, J.F., Medina, F., Col\u00f3n, C., Margolis, H., and Mu\u00f1oz-Jord\u00e1n, J.L. (2013). Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/annotation\/ae27d48b-025f-47ce-8427-4af59f821ad7"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/JVI.73.5.4042-4051.1999","article-title":"Immunotyping of human immunodeficiency virus type 1 (HIV): An approach to immunologic classification of HIV","volume":"73","author":"Gorny","year":"1999","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1128\/JVI.74.22.10670-10680.2000","article-title":"Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes","volume":"74","author":"Nyambi","year":"2000","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aac5017","article-title":"Dengue viruses cluster antigenically but not as discrete serotypes","volume":"349","author":"Katzelnick","year":"2015","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.00273-15","article-title":"Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies","volume":"89","author":"Tsai","year":"2015","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/jcm.22.2.250-254.1985","article-title":"Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: Comparison of the BHK suspension test with standard plaque reduction neutralization","volume":"22","author":"Morens","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Patel, B., Longo, P., Miley, M.J., Montoya, M., Harris, E., and de Silva, A.M. (2017). Dissecting the human serum antibody response to secondary dengue virus infections. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005554"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3201\/eid1302.060539","article-title":"Neutralizing Antibodies after Infection with Dengue 1 Virus","volume":"13","author":"Guzman","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/vim.2007.0050","article-title":"Antibody to dengue 1 detected more than 60 years after infection","volume":"20","author":"Imrie","year":"2007","journal-title":"Viral Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1522136113","article-title":"Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort","volume":"113","author":"Katzelnick","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13071-019-3357-3","article-title":"First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation","volume":"12","author":"Auerswald","year":"2019","journal-title":"Parasit. Vectors"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actatropica.2014.11.009","article-title":"Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections","volume":"142","author":"Libraty","year":"2015","journal-title":"Acta Trop."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1743-422X-11-48","article-title":"Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand","volume":"11","author":"Sirivichayakul","year":"2014","journal-title":"Virol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live Dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"ref_23","first-page":"366","article-title":"Studies on the immunization of monkeys against Dengue. Protection derived from single and sequential virus infections","volume":"22","author":"Halstead","year":"1973","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Auerswald, H., Klepsch, L., Schreiber, S., H\u00fclsemann, J., Franzke, K., Kann, S., Y., B., Duong, V., Buchy, P., and Schreiber, M. (2019). The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study. Viruses, 11.","DOI":"10.3390\/v11040304"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","article-title":"Original antigenic sin in dengue","volume":"32","author":"Halstead","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/infdis\/jix173","article-title":"The Doctrine of Original Antigenic Sin: Separating Good from Evil","volume":"215","author":"Monto","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/JVI.02036-15","article-title":"Divergent viruses discovered in arthropods and vertebrates revise the evolutionary history of the Flaviviridae and related viruses","volume":"90","author":"Shi","year":"2015","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Aguiar, M., Stollenwerk, N., and Halstead, S. (2016). The impact of the newly licensed dengue vaccine in endemic countries. PLoS Negl. Trop. Dis., 10.","DOI":"10.1101\/074062"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S1473-3099(16)30168-2","article-title":"The risks behind Dengvaxia recommendation","volume":"16","author":"Aguiar","year":"2016","journal-title":"Lancet. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/14760584.2017.1276831","article-title":"Consider stopping Dengvaxia administration without immunological screening","volume":"16","author":"Aguiar","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cix882","article-title":"Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent Data","volume":"66","author":"Aguiar","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.apjtm.2016.12.002","article-title":"Serodiagnosis of asymptomatic dengue infection","volume":"10","author":"Chatchen","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kyaw, A.K., Ngwe Tun, M.M., Naing, S.T., Htwe, T.T., Mar, T.T., Khaing, T.M., Aung, T., Aye, K.S., Thant, K.Z., and Morita, K. (2019). Inapparent dengue virus infection among students in Mandalay, Myanmar. Trans. R. Soc. Trop. Med. Hyg.","DOI":"10.1093\/trstmh\/trz071"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4269\/ajtmh.16-0159","article-title":"Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas","volume":"95","author":"Olivero","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections","volume":"5","author":"Grange","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1963","DOI":"10.1002\/rmv.1963","article-title":"Current status on the development of pseudoviruses for enveloped viruses","volume":"28","author":"Li","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-0348-1_6","article-title":"Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection","volume":"1138","author":"Mukherjee","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kretschmer, M., Kadlubowska, P., Hoffmann, D., Schwalbe, B., Auerswald, H., and Schreiber, M. (2020). Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy. Cancers, 12.","DOI":"10.3390\/cancers12041000"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/10\/1957\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:07:15Z","timestamp":1760166435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/10\/1957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["v13101957"],"URL":"https:\/\/doi.org\/10.3390\/v13101957","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}